Alternative Biomedical Solutions (ABS) announced today that Adrian Whipple has been appointed to the position of Chief Financial Officer. Mr. Whipple will be responsible for accounting, financial planning and analysis, treasury, tax, business operations and M&A analysis.
We are bullish on our outlook for the Core Segments for the year ahead and much of it is due to the groundwork that Chris has put in place. It’s been great to have him on our team.
Partnership compliments each company’s strengths and segment expertise to service key markets in Toxicology and Cannabis segments
Partnership compliments each company’s strengths and segment expertise to service key markets in Toxicology and Cannabis segments
Alternative Biomedical Solutions (ABS) announced today the promotion of Yuran Li to Director of MS Commercial Strategies.
Alternative Biomedical Solutions (ABS) announced today the addition of Sue Milo, Business Development Executive.
Alternative Biomedical Solutions (ABS) announced today the launch of its new corporate website
Alternative Biomedical Solutions (ABS) announced today the additon of Rashid Hussain, Business Development Executive
Introducing Yuran Li, MT ASCP, Business Development Executive
Alternative Biomedical Solutions (ABS) Adds Highly Qualified, Well-Rounded Technical Team Member to Support New Customer Needs Introducing Paul Cook, Tele-sales, Business Development Carrollton, TX, Release: May 4, 2021. For Immediate Release Alternative Biomedical Solutions (ABS) announced today the addition of Paul Cook, Telesales Business Development. This appointment supports the technical aspect of the sales strategy …
Introducing Wendy Locklin, MT ASCP, Business Development Executive Alternative Biomedical Solutions (ABS) announced today the addition of Wendy Locklin, Business Development Executive, effective March 1, 2021. This appointment supports the strategy that ABS is implementing new initiatives to drive growth through sales innovation and market penetration. Wendy Locklin joins ABS with over 20 years served …
Introducing Chris Arrington, Vice President, Business Development Carrollton, TX, Release: March 16, 2021. For Immediate Release Alternative Biomedical Solutions (ABS) announced today that its leadership team has appointed Chris Arrington as Vice President of Business Development effective February 15, 2021. This appointment supports the new strategic initiatives to drive growth and innovate service offerings. “I am happy …